Eli Lilly puts $1B on the line to expand its cancer radiopharmaceuticals prospects

The latest stories trending on MedCity News.

Editor's Pick

Top Story Eli Lilly Puts $1B on the Line to Expand its Cancer Radiopharmaceuticals Prospects Eli Lilly is paying $140 million for the exclusive right to buy Radionetics Oncology for the price of $1 billion. The clinical-stage startup, a Crinetics Pharmaceuticals spinout, develops radiopharmaceuticals that target GPCRs overexpressed by solid tumors. Sponsored Streamlining the Patient Consent Process Presented by MedCity News & Docusign Velatura, a leading multi-jurisdictional health information exchange and health data utility, along with Docusign, the leading intelligent agreement management solution that accelerates the process of doing business, have joined forces to streamline the process of obtaining and managing informed patient consent.  Learn more! 4th of July Special! Get $50 Off Your INVEST Digital Health Tickets Join us for MedCity's INVEST Digital Health conference at Pegasus Park, Dallas on September 18, to transform the future of healthcare. This week, we're thrilled to offer a 4th of July ticket promotion!  Take advantage of this limited-time offer to secure your spot and save $50 on tickets. Register using promo code INVEST4TH at checkout by July 5, 11:59 ET. Register Today and Save

Featured News

K Health's Latest Funding Round Brings the Primary Care AI Startup to $380M Raised K Health closed a $50 million equity funding round, which brought its total fundraising amount to $380 million and propelled the startup to a $900 million valuation. The company, which was founded in 2016, uses AI to educate patients about their symptoms and connect them to primary care. 5 Funding Announcements from Payer/Employer Companies In June Here is a list of some of the biggest funding rounds in the payer/employer space that were announced in June. One Conversation Could Be All It Takes to Identify Chronic Kidney Disease No one should ever learn about CKD after their kidneys have already failed. The Role of AI in Empowering Early Lung Cancer Detection & Transforming Patient Outcomes AI-powered solutions for opportunistic lung cancer detection using routine chest X-rays offer hope for improved early diagnosis and survival rates.

Resources

MedCity FemFwd: How Employers Can Improve Maternal Health Outcomes In this episode, we're joined by Randa Deaton, vice president of purchaser engagement at the Purchaser Business Group on Health. She talks about the organization's new Comprehensive Maternity Care Common Purchasing Agreement. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe